Results 71 to 80 of about 3,514 (173)

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BMC Nephrology, 2012
Background Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines.
Bleskestad Inger H, Bergrem Harald, Hartmann Anders, Godang Kristin, Gøransson Lasse G   +4 more
doaj   +1 more source

Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates

Journal of Pharmacy and Bioallied Sciences, 2019
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality.
Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy   +4 more
doaj   +1 more source

The effect of sevelamer on the bone volume in the rat model of osteoporosis

, 2013
Sevelamer hidroklorid (HCl)(Renagel®, Genzyme) fosfatni je vezač koji ne sadrži kalcijeve soli, ne apsorbira se u probavnoj cijevi niti razgrađuje u crijevima.
Drača, Nataša
core   +2 more sources

The impact of sevelamer in aluminum phosphide poisoning: a preliminary study on mortality

Medicina Clínica Práctica
Background: Aluminum phosphide (ALP) poisoning, commonly referred to as rice tablet poisoning, is among the deadliest forms of poisoning. Treatment for aluminum phosphide poisoning is limited to supportive care, as no specific antidote is currently ...
Kiandokht Khorshidi, Maral Ramezani, Mitra Rahimi, Shahin Shadnia, Babak Mostafazadeh, Peyman Erfan Talab Evini   +5 more
doaj   +1 more source

Sevelamer worsen metabolic acidosis in hemodialysis patients

, 2006
Background: Sevelamer hydrochloride, a major phosphate binder for patients on maintenance hemodialysis (MHD) is associated with reduced serum bicarbonate concentration due to hydrochloric acid release in the gut and to the binding of short chain fatty ...
Cirillo M., Di Stazio E., Santoro D., Correale G., Ciacci C., De Santo N. G., Perna A., Iacono G., Frangiosa A., Di Meglio E., Savica V., Marino A., Stellato D., Anastasio P.   +13 more
core  

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer

, 2010
Background. Cardiovascular morbidity and mortality are massively increased in patients with chronic kidney disease (CKD). Sevelamer hydrochloride has been shown to attenuate cardiovascular calcifications in CKD and end-stage renal disease (ESRD) patients.
Busch, Birgit, Vanholder, Raymond, Schlieper, Georg Rainer, Meert, Natalie, Schlieper, Georg, Brandenburg, Vincent Matthias, Holzmann, Stefan, Ketteler, Markus, Floege, Jürgen, Flöge, Jürgen, Jahnen-Dechent, Willi, Meijers, Björn, Fassbender, Walter J., Heussen, Nicole, Fassbender, Walter J, Jahnen-Dechent, Wilhelm, Evenepoel, Pieter   +16 more
core   +1 more source

Supplementary Material for: Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis

Introduction Case reports have suggested a causative role between sevelamer use and subsequent gastrointestinal bleeding (GIB), but no large observational studies have evaluated this association.
Coresh J. (4122835), Crews D.C. (3259464), Le D. (18262351), Grams M.E. (6968099), Shin J.-I. (18262354)   +4 more
core   +1 more source

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action

The Egyptian Journal of Internal Medicine, 2015
Background The non-calcium-based phosphate binder sevelamer hydrochloride was developed to provide chronic kidney disease patients with a polymer capable of managing hyperphosphatemia without an increase in the calcium load.
Bahaa Eldin Zayed, Hussein El-Fishawy, Amal R Al-Shihaby, Mohamed A Salem, Usama A.A. Sharaf El Din, Mona Mansour   +5 more
doaj   +1 more source

Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 9, Page 1144-1146, September 2025.
David Ranzinger, Tobias Schaefer, Franziska Schauer, Kilian Eyerich, Anna Caroline Pilz   +4 more
wiley   +1 more source

Gastric pH, sevelamer hydrochloride and omeprazole

, 2005
Aims: Sevelamer hydrochloride is a polymer containing multiple amines (40% amine hydrochloride) separated by one carbon from the polymer backbone, and it is not absorbed by the intestine.
C. Del Corso, A. Rossi, A. Capitanini, M. Gallieni, F. Osteri, A. Lupi, I. Petrone, M. Straniti   +7 more
core